Novel Approach to Synthesis of Diaryl Tacrine Derivatives and Evaluation of Their Inhibitory Effects on Cholinesterase Enzymes

Fevzi Topal , Salih Ökten , Büşra Albayrak Misir , Ümit Muhammet Koçyığıt , Yavuz Derın , Vildan Enısoğlu Atalay , Ahmet Tutar , Meryem Topal

Chemical Research in Chinese Universities ›› : 1 -9.

PDF
Chemical Research in Chinese Universities ›› :1 -9. DOI: 10.1007/s40242-026-6048-6
Research Article
research-article
Novel Approach to Synthesis of Diaryl Tacrine Derivatives and Evaluation of Their Inhibitory Effects on Cholinesterase Enzymes
Author information +
History +
PDF

Abstract

The development of effective acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitors remains a crucial objective in the treatment of neurodegenerative diseases, including Alzheimer’s disease (AD). In this study, a novel synthetic approach was established to prepare a series of diaryl-substituted tacrine derivatives. Initially, brominated aminobenzonitrile was subjected to Suzuki-Miyaura cross-coupling reactions with various aryl boronic acids to yielding diaryl-substituted aminobenzonitriles at yields of 60%–72%. These intermediates were then cyclized with cyclohexanone and cycloheptanone under Friedländer conditions using BF3·OEt2 as a catalyst, affording six- and seven-membered diaryl tacrine analogues in yields of 52%–68%. All synthesized compounds were characterized by NMR, IR, and elemental analysis. The inhibitory activities of these compounds (7–16) against AChE and BChE were evaluated, and several analogs demonstrated potent dual-enzyme inhibition at nanomolar concentrations. Notably, compounds 8 and 13 exhibited half maximal inhibitory concentration (IC50) values of 6.848 and 8.545 nmol/L for BChE, respectively, indicating strong potential as selective cholinesterase inhibitors. The structure-activity relationship (SAR) analysis revealed the influence of aryl substituents on the potency and selectivity of enzyme inhibition. Compared to previously reported tacrine derivatives, the newly synthesized analogs exhibited superior inhibitory profiles, indicating their potential as lead compounds for further development in AD therapeutics.

Keywords

Acetylcholinesterase (AChE) / Aminobenzonitrile / Aryl / Butylcholinesterase (BChE) / Structure-activity relationship (SAR) / Tacrine

Cite this article

Download citation ▾
Fevzi Topal, Salih Ökten, Büşra Albayrak Misir, Ümit Muhammet Koçyığıt, Yavuz Derın, Vildan Enısoğlu Atalay, Ahmet Tutar, Meryem Topal. Novel Approach to Synthesis of Diaryl Tacrine Derivatives and Evaluation of Their Inhibitory Effects on Cholinesterase Enzymes. Chemical Research in Chinese Universities 1-9 DOI:10.1007/s40242-026-6048-6

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Tang J, Li J, Zhang L, Ma S, Shi D, Zhang Q, Yang L, Wang X, Liu X, Liu CJ. Heterocyclic. Chem., 2012, 49: 533

[2]

Shutske G M, Pierrat F A, Kapples K J, Cornfeldt M L, Szewczak M R, Huger F P, Bores G M, Haroutunian V, Davis K LJ. Med. Chem., 1989, 32: 1805

[3]

Ekiz M, Tutar A, Ökten STetrahedron., 2016, 72: 5323

[4]

Yilmaz R F, Derin Y, Misir B A, Atalay V E, Tutar Ö F F, Ökten S, Tutar AJ. Mol. Struct., 2023, 1291: 135962

[5]

Arslan B S, Derin Y, Mısır B A, Kaya S, Şişman İ, Tutar A, Nebioğlu MJ. Mol. Struc. T., 2022, 1267: 133608

[6]

Arslan B S, Arkan B, Gezgin M, Derin Y, Avcı D, Tutar A, Nebioğlu M, Şişman İJ. Photochem. Photobiol. A: Chem., 2021, 404: 112936

[7]

Derin Y, Arslan B S, Mısır B A, Şişman İ, Nebioğlu M, Tutar AChem. Heterocycl. Compd., 2020, 56: 1542

[8]

Taş S, Döndaş H A, Yaktubay Döndaş N, Poyraz S, Tok T T, Demiray G A, Belveren S, İnce T, Demir Y, Yılmaz M B, Pask C MFuture Med. Chem., 2025, 17: 2361

[9]

Aydin B O, Anil D A, Demir Y, Alagoz M AMol. Divers., 2024, 28: 3739

[10]

Mısır B A, Derin Y, Ökten S, Aydın A, Koçyiğit ÜM, Şahin H, Tutar AJ. Biochem. Mol. Toxicol., 2024, 38: e23706

[11]

Recanatini M, Cavalli A, Belluti F, Piazzi L, Rampa A, Bisi A, Gobbi S, Valenti P, Andrisano V, Bartolini MJ. Med. Chem., 2000, 43: 2007

[12]

Peçanha E P, Fraga C A, Barreiro E J, Braga M F, Pereira E F, Albuquerque E XJ. Braz. Chem. Soc., 2001, 12: 408

[13]

Kasapoğlu Ö, Çakici A, Sağlamtaş R, Salama M, Harb A, Sarıcı B, Demir YChemistrySelect, 2026, 11: e04774

[14]

Eghtedari M, Sarrafi Y, Nadri H, Mahdavi M, Moradi A, Moghadam F H, Emami S, Firoozpour L, Asadipour A, Sabzevari OE. J. M. Chem., 2017, 128: 237

[15]

Gök Y, Demir Y, Haroon M, Sajid Z, Tezcan B, Aktaş A, Demirci Ö, Gülçin İ, İçen Taşkın I, Gürbüz SPolyhedron., 2025, 285: 117931

[16]

Ökten S, Ekiz M, Koçyiğit ÜM, Tutar A, Çelik İ, Akkurt M, Gökalp F, Taslimi P, Gülçin İJ. Mol. Struct., 2019, 1175: 906

[17]

Ökten S, Ekiz M, Tutar A, Butun B, Kocyigit U M, Topcu G, Gulcin IIndian J. Pharm. Educ. Res., 2019, 53: 268

[18]

Ökten S, Aydın A, Tutar AS. Univ. J. Sci., 2019, 23: 824

[19]

Bulut M, Ökten S, Özcan E, Eren TLett. Drug. Des. Discov., 2024, 21: 101

[20]

Topal FInt. J. Food Prop., 2019, 22: 583

[21]

Topal MInt. J. Food Prop., 2019, 22: 1527

[22]

İnan Ergün A, Topal MChemistrySelect., 2023, 8: e202302751

[23]

Göçer H, Topal F, Topal M, Küçük M, Teke D, Gülçin I, Alwasel S H, Supuran C TJ. Enzyme Inhib. Med. Chem., 2016, 31: 441

[24]

Demir Y, Şenol H, Uluçay O, Ateşoğlu Ş, Tokalı F SComput. Biol. Chem., 2025, 120: 108683

[25]

Topal F, Yılmaz F, Topal M, Menevşeoğlu ATURJAF, 2025, 13: 204

[26]

Demir Y, Ceylan H, Yeşilkent E N, Kizir D, Karaman M, Türkeş C, Beydemir ŞComput. Biol. Chem., 2025, 120: 108654

[27]

Kuzu B, Alagoz M A, Demir Y, Gulcin I, Burmaoglu S, Algul OMol. Divers., 2025, 29: 671

[28]

Orhan I E, Tosun F, Skalicka-Woźniak KJ. Serb. Chem. Soc., 2016, 81: 357

[29]

Gezegen H, Özbek O, Topal M, Şahin H, Koçyiğit ÜMBiotechnol. Appl. Biochem., 2025, 73: 14

[30]

Kuzu B, Demir YChem. Pap., 2025, 79: 2005

[31]

Shirisha T, Majhi S, Divakar K, Kashinath DOrg. Biomol. Chem., 2024, 22: 790

[32]

Topal FJ. Biochem. Mol. Toxicol., 2019, 33: e22385

[33]

Ashleigh T, Swerdlow R H, Beal M FAlzheimer’s Demen., 2023, 19: 333

[34]

Muğlu H, Yakan H, Erdoğan M, Topal F, Topal M, Türkeş C, Beydemir ŞNew J. Chem., 2024, 48: 10979

[35]

Erdoğan M, Onder A, Demir Y, Comert Onder FACS Omega, 2024, 9: 46860

[36]

Tokalı F S, Şenol H, Demir Y, Uluçay O, Ameen M, Shafiq ZRSC Advances, 2025, 15: 50186

[37]

Barta C, Sasvari-Szekely M, Devai A, Kovacs E, Staub M, Enyedi PMol. Genet. Metab., 2001, 74: 484

[38]

Behl T, Kaur I, Sehgal A, Singh S, Sharma N, Gupta S, Albratty M, Najmi A, Alhazmi H A, Bungau SAgeing Res. Rev., 2023, 83: 101787

[39]

Bhatia V, Sharma SJ. Neurol. Sci., 2021, 421: 117253

[40]

Remya C, Dileep K V, Reddy E K, Mantosh K, Lakshmi K, Jacob R S, Sajithf A M, Variyar E J, Anwar S, Zhang K Y J, Sadasivan C, Omkumar R VComput. Struct. Biotechnol. J., 2021, 19: 4517

[41]

Liu W, Wu L, Li D, Huang Y, Liu M, Liu W, Tian C, Liu X, Jiang X, Hu X, Gao X, Xu Z, Lu H, Zhao QBioorg. Chem., 2022, 126: 105875

[42]

Reddy E K, Remya C, Mantosh K, Sajith A M, Omkumar R V, Sadasivan C, Anwar SEur. J. Med. Chem., 2017, 139: 367

[43]

Kuzu B, Demir YArch. Biochem. Biophys., 2025, 771: 110504

[44]

Derabli C, Boualia I, Abdelwahab A B, Boulcina R, Bensouici C, Kirsch G, Debache ABioorg. Med. Chem. Lett., 2018, 28: 2481

RIGHTS & PERMISSIONS

Jilin University, The Editorial Department of Chemical Research in Chinese Universities and Springer-Verlag GmbH

PDF

8

Accesses

0

Citation

Detail

Sections
Recommended

/